Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000420864 | SCV000527220 | likely benign | not specified | 2016-04-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001521073 | SCV001730330 | benign | Duchenne muscular dystrophy | 2024-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429408 | SCV002742991 | likely benign | Cardiovascular phenotype | 2022-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004703965 | SCV005209199 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001833543 | SCV002089710 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-05-01 | no assertion criteria provided | clinical testing |